Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
"Material Time, Material Extent" Proposed Rule Issued By FDA
The safety profile of foreign OTC drugs requiring pharmacist intervention will be the deciding factor in FDA decisions on whether some drug ingredients sold outside the U.S. are eligible to be considered for inclusion in an OTC drug monograph.
More from Archive
More from Pink Sheet
• By
The new recommendations should not change insurance coverage, but the tone of the meeting frustrated many medical experts, because of the negative comments on the vaccines.
• By
Confusion, inconsistency and strongly held views complicated the CDC's Advisory Committee on Immunization Practices' votes to change vaccine recommendations for the measles, mumps, rubella, varicella vaccine in young children and tabling of a vote on hepatitis B vaccine at birth.
• By
The newly issued Make America Healthy Again strategy report suggests that FDA leaders are doing a good job of feeding ideas to the Trump Administration, rather than having the agency agenda dictated from above.